Nabsys Raises $21 Million Equity Round Led by Hitachi High-Technologies

Wednesday, October 2, 2019 General News
Email Print This Page Comment bookmark
Font : A-A+

PROVIDENCE, R.I., Oct. 2, 2019 /PRNewswire/ -- Nabsys, the pioneer in high-definition genome mapping, announced today that it has closed on a $21 million equity round led by Hitachi High-Technologies Corporation.  

Nabsys will use the funding to finalize product development and support global commercial launch of their HD-Mapping™ whole-genome

electronic mapping platform.  

HD-Mapping has applications in a wide variety of key research applications, including de novo assembly, structural variant analysis, metagenome characterization, and strain identification, as well as in next-generation cytogenetics. Nabsys electronic mapping enables routine, scalable analysis of genomic structural variation. 

Mr. Tsuyoshi Ogino, General Manager, Innovation Division at Hitachi High-Technologies said, "There is a strong need for accurate, robust, and scalable genomic structural analysis for cytogenetic, cancer, and infectious disease research. Hitachi High-Technologies determined that the Nabsys HD-Mapping approach effectively supports this need. The company is also a strong fit with our strategy for continued advanced R&D with strategic investments in life sciences."

"This investment round will help Nabsys fulfill its mission to make the analysis of large- and intermediate-scale genomic variation as routine, accurate, and cost-effective as the analysis of single-nucleotide variation," said Barrett Bready, M.D., Founder and CEO at Nabsys.

About Hitachi High-Technologies Corporation:Hitachi High-Technologies Corporation, headquartered in Tokyo, Japan, is engaged in activities in a broad range of fields, including Analytical & Medical Solutions (manufacture and sales of clinical analyzers, biotechnology products, and analytical instruments), Nano-Technology Solutions (manufacture and sales of semiconductor manufacturing equipment and analysis equipment), and Industrial Solutions (providing high value-added solutions in fields of social & industrial infrastructures and mobility, etc.). The company's consolidated revenues for FY 2018 were approx. JPY 731.1 billion [USD 6.6 billion]. For further information, visit http://www.hitachi-hightech.com/global/

About Nabsys:Nabsys is the leader in high-definition electronic genome mapping.  Nabsys uses proprietary electronic nanochannel detectors to analyze long DNA molecules at high velocity.  Nabsys HD-Mapping™ whole genome maps with sub-diffraction-limit resolution, provide compelling advantages for the analysis of genomic structural variation, genome assembly, and high-specificity strain identification.   For further information, visit http://www.nabsys.com

Contact:

NabsysBrian Paras VP, Commercial Development info@nabsys.com

Cision View original content:http://www.prnewswire.com/news-releases/nabsys-raises-21-million-equity-round-led-by-hitachi-high-technologies-300929091.html

SOURCE Nabsys



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store